About 100 reports

  • MERCK
  • LONZA

LONZA: OPPORTUNITY ASSESSMENT Opportunity Assessment Merck delivers novel health solutions through its prescription medicines, biologic therapies, and consumer care products.

  • Biological Therapy
  • United States
  • Forecast
  • Merck & Co., Inc.
  • Sanofi S.A.

The drug is the only approved first-line biologic in the region for the treatment of psoriasis.

  • Biological Therapy
  • United States
  • Biogen Idec Inc.
  • Seattle Genetics, Inc.
  • Takeda Pharmaceutical Company Limited

THIS ALLIANCE WAS FORMED ON A PRIOR AGREEMENT BETWEEN WUXI BIOLOGICS AND MEDIMMUNE ON THE DEVELOPMENT AND COMMERCIALIZATION OF MEDI##, A NOVEL BIOLOGIC DEVELOPED FOR THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES.

  • Biological Therapy
  • Biopharmaceutical
  • Cell Therapy
  • Manufacturing
  • United States
  • 9. KEY THERAPEUTIC AREAS FOR T-CELL THERAPIES
  • 6. T-CELL RECEPTOR (TCR) BASED THERAPIES

CMC BIOLOGICS ##. ##. ##.

  • Biological Therapy
  • United States
  • Juno Therapeutics Inc.
  • Kite Pharma, Inc.
  • Novartis AG

Physician Views: Can new biologic therapies expand the severe asthma market?

  • Asthma
  • Biological Therapy
  • Therapy
  • United States
  • Forecast
  • 5. VIRAL VECTORS

COBRA BIOLOGICS ##. ##. ##.

  • Biological Therapy
  • United States
  • Market Size
  • MolMed S.p.A.
  • uniQure N.V.
  • T-CELL RECEPTOR (TCR) THERAPIES

NOVEL TREATMENTS FORM ANOTHER ARM OF THE AVAILABLE THERAPIES WHICH INCLUDES THE BIOLOGIC THERAPY.

  • Biological Therapy
  • United States
  • Cellectis S.A.
  • Juno Therapeutics Inc.
  • Kite Pharma, Inc.

The company mainly focuses on various health solutions such as prescription medicines, vaccines, biologic therapies, animal health and biologic products worldwide.

  • Biological Therapy
  • Cardiovascular Disease
  • Gene Therapy
  • Therapy
  • United States

BIOMET BIOLOGICS/ BIOMET CLINICALTRIALS.

  • Biological Therapy
  • United States
  • Athersys, Inc.
  • ISCC
  • Vericel Corporation
  • Deal Type

" Recent publications and presentations continue to illustrate how we might be able to extend the treatment window for stroke patients out to ## hours with MultiStem, beyond the narrow window for treatment that exists today, and also the important biological mechanisms

  • Biological Therapy
  • Stroke
  • United States
  • Company
  • Athersys, Inc.
  • BIMEKIZUMAB - DRUG PROFILE

Using a Bayesian statistical analysis, there was high posterior probability (##%) that the ACR## RR of bimekizumab at Week ## was greater than those reported for current standard of care biologic treatments, including anti-IL-##A therapies.

  • Biological Therapy
  • Cytokine
  • Hospital
  • Interleukin
  • United States

The company' s product portfolio includes biologics, prescription pharmaceuticals and vaccines.

  • Biological Therapy
  • Pathology
  • Pharmaceutical
  • Therapy
  • United States
  • 05/01/2017: Selecta Biosciences Announces Presentations at the 20th Annual Meeting of the American Society of Gene & Cell Therapy
  • May 15, 2017: Selecta Biosciences Announces New Preclinical Gene Therapy Data at the Annual Meeting of the American Society of Gene & Cell Therapy

We believe that SVP-Rapamycin has the potential to mitigate ADAs against a broad range of biologic therapies.

  • Biological Therapy
  • Pharmaceutical
  • United States
  • Company
  • Selecta Biosciences, Inc.
  • Lymphocyte Activation Gene 3 Protein (Protein FDC or CD223 or LAG3) - Companies Involved in Therapeutics Development

Merck & Co Inc (Merck) focuses on the discovery, development, manufacture and commercialization of prescription pharmaceuticals, biologic therapies, vaccines and animal healthcare products.

  • Biological Therapy
  • United States
  • World
  • Product Initiative
  • Bristol-Myers Squibb Company

These will be the first ever adequately powered long-term head-to-head studies with biologic medicines to differentiate the effectiveness of treatment in these conditions.

  • Autoimmune Disease
  • Biological Therapy
  • United States
  • Product Initiative
  • Novartis AG
  • LENZILUMAB - DRUG PROFILE

Evidence of biologic activity was observed.

  • Biological Therapy
  • Breast Cancer
  • Cancer
  • Therapy
  • United States

The CBER regulates biologics including allergenic extracts blood and blood components, gene therapy products, devices and test kits human tissue and cellular products used in transplantation and vaccines.

  • Biological Therapy
  • Cell Therapy
  • United States
  • Market Size
  • Selexis SA

The CBER regulates biologics including allergenic extracts blood and blood components, gene therapy products, devices and test kits human tissue and cellular products used in transplantation and vaccines.

  • Biological Therapy
  • Cell Therapy
  • United States
  • Market Size
  • Selexis SA

Amicus is leveraging its biologics capabilities and CHART (Chaperone-Advanced Replacement Therapy) platform to develop a next-generation Pompe ERT.

  • Biological Therapy
  • Neurological Disorder
  • Therapy
  • United States
  • Product Initiative
  • XBIOTECH USA, INC.
  • CV-18C3 - DRUG PROFILE

(XBiotech) is a bio-pharmaceutical company that develops biological therapies and treatments.

  • Biological Therapy
  • Therapy
  • United States
  • Product Initiative
  • XBiotech Inc.

RESULTS DEMONSTRATED THAT ANEUSTAT WAS WELL TOLERATED AT ALL DOSES TESTED AND HAD DOSE-RESPONSIVE BIOLOGICAL ACTIVITY IN PATIENTS WITH ADVANCED TREATMENT REFRACTORY CANCER.

  • Biological Therapy
  • Cytokine
  • Hospital
  • Therapy
  • United States

Orphan drug designations are granted to drugs or biologics that are being investigated for the treatment of a rare disease or condition.

  • Biological Therapy
  • Pharmaceutical
  • Therapy
  • United States
  • TiGenix NV
  • Lymphocyte Activation Gene 3 Protein (Protein FDC or CD223 or LAG3) - Companies Involved in Therapeutics Development

BRISTOL-MYERS SQUIBB COMPANY PIPELINE BY BRISTOL-MYERS SQUIBB COMPANY, H## 2017 CRESCENDO BIOLOGICS LTD PIPELINE BY CRESCENDO BIOLOGICS LTD, H## 2017 ENUMERAL BIOMEDICAL HOLDINGS INC Crescendo Biologics Ltd (Crescendo) is a biopharmaceutical company that manufactures antibod

  • Biological Therapy
  • Monoclonal Antibody
  • United States
  • Product Initiative
  • Bristol-Myers Squibb Company

Merck & Co Inc (Merck) focuses on the discovery, development, manufacture and commercialization of prescription pharmaceuticals, biologic therapies, vaccines and animal healthcare products.

  • Biological Therapy
  • Healthcare
  • Pharmaceutical
  • United States
  • FUJIFILM Holdings Corporation

ADMA BIOLOGICS, INC.

  • Biological Therapy
  • Genetic Disorder
  • Infectious Disease
  • Therapy
  • United States

Jul ##, 2010 R and D info Osiris Therapeutics, Inc. announced that the Biologics and Genetic Therapies Directorate of Health Canada has completed its initial evaluation and accepted for full review the company' s New Drug Submission (NDS) of Prochymal (remestemcel-L), an adult s

  • Biological Therapy
  • R&D
  • Research And Development
  • Therapy
  • United States
  • AEGLEA BIOTHERAPEUTICS ENTERS INTO AGREEMENT WITH MERCK

Deal Rationale Merck & Co Inc (Merck) focuses on the discovery, development, manufacture and commercialization of prescription pharmaceuticals, biologic therapies, vaccines and animal healthcare products.

  • Biological Therapy
  • Biotherapeutic
  • United States
  • Company
  • Aeglea BioTherapeutics

Its research and development activities involve peptides, small molecule drugs, and other potential biologic drug candidates.

  • Biological Therapy
  • Monoclonal Antibody
  • Therapy
  • United States
  • Product Initiative

Merck & Co Inc (Merck) focuses on the discovery, development, manufacture and commercialization of prescription pharmaceuticals, biologic therapies, vaccines and animal healthcare products.

  • Biological Therapy
  • Healthcare
  • United States
  • Company
  • GE Healthcare Limited
  • PARTNERSHIPS

The company develops vaccines, therapeutics and other biologic products.

  • Biological Therapy
  • Therapy
  • United States
  • Company
  • RegenxBio Inc.